On Friday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Herbalife Ltd. (NYSE:HLF), Envivio, Inc. (NASDAQ:ENVI), SeaDrill Limited (NYSE:SDRL)
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), with shares inclined 4.94%, closed at $27.64.
Herbalife Ltd. (NYSE:HLF), with shares jumped 10.96%, settled at $42.10.
Envivio, Inc. (NASDAQ:ENVI), with shares skyrocketed 27.92%, and closed at $1.97.
SeaDrill Limited (NYSE:SDRL), surged 4.91%, and closed at $9.83.
Latest NEWS regarding these Stocks are depicted underneath:
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
Formerly on March 12, Intra-Cellular Therapies, Inc. (ITCI), a biopharmaceutical corporation focused on the development of therapeutics for central nervous system (CNS) disorders, declared its financial results for the fourth quarter and year ended December 31, 2014, and offered a corporate update.
Selected Fourth Quarter and Year End 2014 Financial Results:
The Corporation stated a net loss of $15.2 million, or $(0.52) per share (basic and diluted), for the fourth quarter of 2014 contrast with a net loss of $8.0 million, or $(0.36) per share (basic and diluted), for the fourth quarter of 2013. The Corporation stated a net loss of $30.7 million, or $(1.07) per share (basic and diluted), for the full year ended December 31, 2014 contrast with a net loss of $26.9 million, or $(1.56) per share (basic and diluted), for the same period in 2013.
Research and development (R&D) expenses for the fourth quarter of 2014 were $11.6 million, contrast to $6.1 million for the fourth quarter of 2013. For the full year ended December 31, 2014, R&D expenses were $21.2 million, contrast to $23.0 million for 2013. The decrease year over year is due primarily to costs associated with outside clinical testing for our ITI-007 Phase 2 clinical trial that was accomplished in late 2013, offset by raised costs incurred in the fourth quarter of 2014 as a result of the initiation of our ITI-007 Phase 3 clinical trial.
General and administrative (G&A) expenses were $3.7 million for the fourth quarter of 2014, contrast to $2.7 million for the fourth quarter of 2013. For the full year ended December 31, 2014, G&A expenses were $10.3 million, contrast to $6.0 million for the preceding-year period. These raises were primarily due to raised stock option expense in 2014 related to options granted in 2014, and raised labor and related benefit costs, with the remainder comprised of higher professional fees, directors’ and officers’ insurance costs, and board of directors’ compensation due to being a public corporation.
Cash, cash equivalents and investment securities totaled $129.6 million at December 31, 2014, contrast to $37.2 million at December 31, 2013. The raise is due to the Corporation raising net proceeds of about $115.4 million in a public offering of its ordinary stock during the first quarter of 2014, offset by cash used in operations during the year. On March 11, 2015 the Corporation accomplished an underwritten public offering of its ordinary stock for gross proceeds of about $130 million and net proceeds of about $121.4 million, after deducting underwriting discounts and commissions and estimated offering expenses.
The Corporation anticipates that its existing cash, cash equivalents and investment securities will be dedicated primarily to the ITI-007 clinical platform and pre-clinical activities. To a much lesser extent, funds will be used for other development programs the Corporation is undertaking, counting our phosphodiesterase (PDE) programs.
Intra-Cellular Therapies, Inc., a biopharmaceutical corporation, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS).
Herbalife Ltd. (NYSE:HLF)
On March 18, Herbalife Ltd. (HLF), issued the following statement:
“Herbalife welcomes the decision by the U.S. District Court for the Central District of California to dismiss the case. As we have consistently stated, we are confident in the strong fundamentals of our business model and remain committed to assisting people and communities improve their nutrition.”
While, on March 13, Global nutrition corporation sponsored the Hispanas Organized for Political Equality (HOPE) 24th Annual Latina History Day Conference, held at the Millennium Biltmore Hotel in Los Angeles.
Herbalife Ltd., a nutrition corporation, develops and sells weight administration, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products.
Envivio, Inc. (NASDAQ:ENVI)
Envivio, Inc. (ENVI), a leading provider of software-based video processing and delivery solutions, declared financial results for the fourth quarter and fiscal year 2015 ending January 31, 2015.
Q4 Business and Product Highlights:
- Tier 1 Operator Proceed - Three U.S. and one international Tier 1 service providers contributed noteworthy proceed from incremental purchases of Envivio products and services.
- New Customers - Envivio added four new customers to its roster of leading broadcast and operator companies.
- Customer Expansions and Wins - French mobile operator Bouyges Telecom chose Envivio for multiple services, while Taiwanese telecom operator Chunghwa chose Envivio to power its 4K HEVC trial.
- Envivio Board Appointment - Former Time Warner EVP and CTO Mike LaJoie has joined the Envivio Board of Directors. Mr. LaJoie has a deep understanding of Envivio’s customers and technology.
- Global Market Leadership Award - Renowned analyst firm Frost and Sullivan named Envivio the #1 global vendor for Live Video Transcoding (Media and Entertainment). This prestigious industry award also highlighted Envivio for its innovation and capturing the highest proceed share in the live transcoding segment. It also recognized Envivio for being best in class for customer value, and for offering a unified approach to new-age Pay TV Services.
- Mobile World Congress, Partnering with Huawei - At the recent Mobile World Congress, Envivio partnered with Huawei and Sony to demonstrate 4K HEVC in action.
Envivio, Inc. provides software-based IP video processing and distribution solutions that enable the delivery of high-quality video to consumers worldwide. The corporation designs its solutions, based on its video compression and advanced IP video networking technologies, to enable service providers and content providers to offer high-quality video across various video formats, networks, consumer devices, and operating systems.
SeaDrill Limited (NYSE:SDRL)
SeaDrill Limited (SDRL), declared its fourth quarter results for the three months ended December 31, 2014.
Financial Highlights:
- The Seadrill Group on a combined basis reports EBITDA of US$897 million, a year over year raise of 17%
- Seadrill Limited reports fourth quarter 2014 EBITDA* of US$672 million
- Seadrill Limited reports fourth quarter 2014 net revenue of US$150 million and earnings per share of US$0.32
- Seadrill Group on a combined basis reports orderbacklog of about US$17.2 billion
- Seadrill Limited sells the ultra-deepwater drillship West Vela to Seadrill Partners for US$900 million on a 100% basis. Seadrill Limited sold a 51% stake in the unit.
- Seadrill receives commitments for a US$750 million credit facility for SeaMex to refinance the West Oberon, West Intrepid, West Defender, West Courageous, and West Titania.
- Seadrill receives commitments for a US$950 million credit facility for the financing of the West Carina and West Eclipse.
- Seadrill exercises a purchase option for the West Polaris, a 6th generation Ultra-Deepwater drillship, from Ship Finance International Ltd. The purchase option price is US$456 million and total consideration payable to Ship Finance is US$111 million after accounting for existing debt on the unit.
Seadrill Limited, an offshore drilling contractor, provides offshore drilling services to the oil and gas industry worldwide. The corporation operates in three segments: Floaters, Jack-up Rigs, and Tender Rigs. The Floaters segment offers services, such as drilling, completion, and maintenance of offshore exploration and production wells under contracts regarding semi-submersible rigs and drillships for harsh and benign environments in mid, deep, and ultra-deep waters.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
